CSF3 and breast carcinoma: Strikingly, a Cochrane Database Systematic Review including eight randomized clinical trials assessing the effect of prophylactic G-CSF showed evidence of prevention of febrile neutropenia but failed to confirm any effect on maintaining dose density in breast cancer patients [14].